Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment

Biochemical and Biophysical Research Communications

Volumn 354, Issue 3, 2007, Pages 700-706

  Iso, Yoshitaka ^a,b   Spees, Jeffrey L ^a,b   Serrano, Claudia ^c   Bakondi, Benjamin ^b   Pochampally, Radhika ^a   Song, Yao Hua ^c   Sobel, Burton E ^b   Delafontaine, Patrick ^c   Prockop, Darwin J ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c Tulane Center for Cardiovascular Health   (United States)

Author keywords

Cellular engraftment; Cytoprotection; Multipotent stromal cells; Myocardial infarction; Secreted factors

Indexed keywords

ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL FUSION; CELL THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENGRAFTMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; ISCHEMIA; MICROARRAY ANALYSIS; PARACRINE SIGNALING; PRIORITY JOURNAL; STROMA CELL;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROSIS; HUMANS; MICE; MULTIPOTENT STEM CELLS; MYOCARDIAL INFARCTION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STROMAL CELLS; TIME FACTORS;

MUS;

EID: 33846639224     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.01.045     Document Type: Article

References (27)

1. Boyle A.J., Schulman S.P., Hare J.M., and Oettgen P. Is stem cell therapy ready for patients? Stem cell therapy for cardiac repair. Ready for the next step. Circulation 114 (2006) 339-352
2. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Pickel J., McKay R., Nadal-Ginard B., Bodine D.M., Leri A., and Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
3. Mangi A.A., Noiseux N., Kong D., He H., Rezvani M., Ingwall J.S., and Dzau V.J. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9 (2003) 1195-1201
4. Prockop D.J., Gregory C.A., and Spees J.L. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc. Natl. Acad. Sci. USA 100 Suppl. (2003) 11917-11923
5. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., and Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 (2004) 668-673
6. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., Pasumarthi K.B., Virag J.I., Bartelmez S.H., Poppa V., Bradford G., Dowell J.D., Williams D.A., and Field L.J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
7. Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., Sano M., Takahashi T., Hori S., Abe H., Hata J., Umezawa A., and Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103 (1999) 697-705
8. Amado L.C., Saliaris A.P., Schuleri K.H., St John M., Xie J.S., Cattaneo S., Durand D.J., Fitton T., Kuang J.Q., Stewart G., Lehrke S., Baumgartner W.W., Martin B.J., Heldman A.W., and Hare J.M. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. USA 102 (2005) 11474-11479
9. Kudo M., Wang Y., Wani M.A., Xu M., Ayub A., and Ashraf M. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J. Mol. Cell. Cardiol. 35 (2003) 1113-1119
10. Silva G.V., Litovsky S., Assad J.A., Sousa A.L., Martin B.J., Vela D., Coulter S.C., Lin J., Ober J., Vaughn W.K., Branco R.V., Oliveira E.M., He R., Geng Y.J., Willerson J.T., and Perin E.C. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111 (2005) 150-156
11. Nagaya N., Fujii T., Iwase T., Ohgushi H., Itoh T., Uematsu M., Yamagishi M., Mori H., Kangawa K., and Kitamura S. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H2670-H2676
12. Kollet O., Peled A., Byk T., Ben-Hur H., Greiner D., Shultz L., and Lapidot T. Beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 95 (2000) 3102-3105
13. Gnecchi M., He H., Liang O.D., Melo L.G., Morello F., Mu H., Noiseux N., Zhang L., Pratt R.E., Ingwall J.S., and Dzau V.J. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11 (2005) 367-368
14. Gnecchi M., He H., Noiseux N., Liang O.D., Zhang L., Morello F., Mu H., Melo L.G., Pratt R.E., Ingwall J.S., and Dzau V.J. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 20 (2006) 661-669
15. Kinnaird T., Stabile E., Burnett M.S., Lee C.W., Barr S., Fuchs S., and Epstein S.E. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 94 (2004) 678-685
16. Urbich C., Aicher A., Heeschen C., Dernbach E., Hofmann W.K., Zeiher A.M., and Dimmeler S. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol. 39 (2005) 733-742
17. Munoz J.R., Stoutenger B.R., Robinson A.P., Spees J.L., and Prockop D.J. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc. Natl. Acad. Sci. USA 102 (2005) 18171-18176
18. Bartunek J., Vanderheyden M., Vandekerckhove B., Mansour S., De Bruyne B., De Bondt P., Van Haute I., Lootens N., Heyndrickx G., and Wijns W. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112 Suppl. (2005) I178-I183
19. Miller F.J., Rosenfeldt F.L., Zhang C., Linnane A.W., and Nagley P. Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: lack of change of copy number with age. Nucleic Acids Res. 31 (2003) e61
20. Limana F., Urbanek K., Chimenti S., Quaini F., Leri A., Kajstura J., Nadal-Ginard B., Izumo S., and Anversa P. Bcl-2 overexpression promotes myocyte proliferation. Proc. Natl. Acad. Sci. USA 99 (2002) 6257-6262
21. Spees J.L., Olson S.D., Whitney M.J., and Prockop D.J. Mitochondrial transfer between cells can rescue aerobic respiration. Proc. Natl. Acad. Sci. USA 103 (2006) 1283-1288
22. Bentzon J.F., Stenderup K., Hansen F.D., Schroder H.D., Abdallah B.M., Jensen T.G., and Kassem M. Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene. Biochem. Biophys. Res. Commun. 330 (2005) 633-640
23. Barbash I.M., Chouraqui P., Baron J., Feinberg M.S., Etzion S., Tessone A., Miller L., Guetta E., Zipori D., Kedes L.H., Kloner R.A., and Leor J. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108 (2003) 863-868
24. Schachinger V., Assmus B., Britten M.B., Honold J., Lehmann R., Teupe C., Abolmaali N.D., Vogl T.J., Hofmann W.K., Martin H., Dimmeler S., and Zeiher A.M. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol. 44 (2004) 1690-1699
25. Hirota H., Chen J., Betz U.A., Rajewsky K., Gu Y., Ross Jr. J., Muller W., and Chien K.R. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97 (1999) 189-198
26. Tammela T., Enholm B., Alitalo K., and Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc. Res. 65 (2005) 550-563
27. Okumura H., Nagaya N., Itoh T., Okano I., Hino J., Mori K., Tsukamoto Y., Ishibashi-Ueda H., Miwa S., Tambara K., Toyokuni S., Yutani C., and Kangawa K. Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation 109 (2004) 242-248